Logo image of SOL

EMEREN GROUP LTD (SOL) Stock Fundamental Analysis

USA - NYSE:SOL - US75971T3014 - ADR

1.82 USD
-0.02 (-1.09%)
Last: 10/17/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, SOL scores 4 out of 10 in our fundamental rating. SOL was compared to 54 industry peers in the Construction & Engineering industry. The financial health of SOL is average, but there are quite some concerns on its profitability. SOL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SOL had positive earnings in the past year.
In the past year SOL had a positive cash flow from operations.
In multiple years SOL reported negative net income over the last 5 years.
In the past 5 years SOL always reported negative operating cash flow.
SOL Yearly Net Income VS EBIT VS OCF VS FCFSOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

The Return On Assets of SOL (-0.89%) is worse than 70.37% of its industry peers.
SOL's Return On Equity of -1.27% is on the low side compared to the rest of the industry. SOL is outperformed by 68.52% of its industry peers.
Industry RankSector Rank
ROA -0.89%
ROE -1.27%
ROIC N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
SOL Yearly ROA, ROE, ROICSOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Gross Margin of SOL (29.65%) is better than 81.48% of its industry peers.
SOL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SOL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
SOL Yearly Profit, Operating, Gross MarginsSOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

5

2. Health

2.1 Basic Checks

SOL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SOL has less shares outstanding
SOL has more shares outstanding than it did 5 years ago.
SOL has a worse debt/assets ratio than last year.
SOL Yearly Shares OutstandingSOL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SOL Yearly Total Debt VS Total AssetsSOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.55, we must say that SOL is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SOL (-0.55) is worse than 87.04% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that SOL is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.18, SOL is doing good in the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -0.55
ROIC/WACCN/A
WACC10.67%
SOL Yearly LT Debt VS Equity VS FCFSOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

SOL has a Current Ratio of 4.24. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.24, SOL belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
A Quick Ratio of 4.24 indicates that SOL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.24, SOL belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.24
Quick Ratio 4.24
SOL Yearly Current Assets VS Current LiabilitesSOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

SOL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 215.38%, which is quite impressive.
SOL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.92%.
The Revenue has been decreasing by -5.02% on average over the past years.
EPS 1Y (TTM)215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5500%
Revenue 1Y (TTM)-33.92%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-57.14%

3.2 Future

SOL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.80% yearly.
SOL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.79% yearly.
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOL Yearly Revenue VS EstimatesSOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SOL Yearly EPS VS EstimatesSOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.04, the valuation of SOL can be described as very cheap.
SOL's Price/Earnings ratio is rather cheap when compared to the industry. SOL is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of SOL to the average of the S&P500 Index (27.40), we can say SOL is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.79, the valuation of SOL can be described as reasonable.
Based on the Price/Forward Earnings ratio, SOL is valued cheaply inside the industry as 98.15% of the companies are valued more expensively.
SOL is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.04
Fwd PE 8.79
SOL Price Earnings VS Forward Price EarningsSOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOL Per share dataSOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SOL's earnings are expected to grow with 72.80% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y72.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SOL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMEREN GROUP LTD

NYSE:SOL (10/17/2025, 8:04:00 PM)

1.82

-0.02 (-1.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-19 2025-08-19/amc
Earnings (Next)11-12 2025-11-12/amc
Inst Owners42.56%
Inst Owner Change0%
Ins Owners1.06%
Ins Owner Change0%
Market Cap93.41M
Analysts80
Price Target7.14 (292.31%)
Short Float %17.56%
Short Ratio5.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5694.06%
Min EPS beat(2)199.01%
Max EPS beat(2)11189.1%
EPS beat(4)3
Avg EPS beat(4)2751.57%
Min EPS beat(4)-384.65%
Max EPS beat(4)11189.1%
EPS beat(8)3
Avg EPS beat(8)569.61%
EPS beat(12)5
Avg EPS beat(12)393.57%
EPS beat(16)6
Avg EPS beat(16)275.05%
Revenue beat(2)0
Avg Revenue beat(2)-36.03%
Min Revenue beat(2)-40.72%
Max Revenue beat(2)-31.34%
Revenue beat(4)0
Avg Revenue beat(4)-34.57%
Min Revenue beat(4)-51.47%
Max Revenue beat(4)-14.76%
Revenue beat(8)2
Avg Revenue beat(8)-18.93%
Revenue beat(12)3
Avg Revenue beat(12)-21.56%
Revenue beat(16)3
Avg Revenue beat(16)-26.14%
PT rev (1m)55.56%
PT rev (3m)55.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.04
Fwd PE 8.79
P/S 1.36
P/FCF N/A
P/OCF 18.42
P/B 0.3
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)0.45
EY24.73%
EPS(NY)0.21
Fwd EY11.38%
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)0.1
OCFY5.43%
SpS1.33
BVpS6.05
TBVpS6.05
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.89%
ROE -1.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.65%
FCFM N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 168.87%
Cap/Sales 20.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.24
Quick Ratio 4.24
Altman-Z -0.55
F-Score4
WACC10.67%
ROIC/WACCN/A
Cap/Depr(3y)305.97%
Cap/Depr(5y)240.17%
Cap/Sales(3y)29.54%
Cap/Sales(5y)22.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)215.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5500%
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.92%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%-57.14%
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-76.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.11%
OCF growth 3YN/A
OCF growth 5YN/A